Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
International Journal of Molecular Sciences, 2020 Central hypogonadism is a clinical condition, characterized by sexual symptoms and low serum testosterone levels, due to an impaired function of the hypothalamus or pituitary gland.
V. Ide, D. Vanderschueren, L. Antonio
semanticscholar +1 more source
Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications [PDF]
, 2017 The principle steroidal androgens are testosterone and its metabolite 5α-dihydrotestosterone (DHT), which is converted from testosterone by the enzyme 5α-reductase.
Ahmed, S. Faisal +4 more
core +1 more source
F1000Research, 2019 Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years.
Tharu Tharakan +3 more
doaj +1 more source
Issues Surrounding Testosterone Replacement Therapy [PDF]
Hospital Pharmacy, 2016 Testosterone is derived from Leydig cells and exerts its effects on androgen receptors to influence growth, mood, voice, and several other bodily functions. As men age, their testosterone levels decline. Human immunodeficiency virus (HIV) infection has also been associated with lowered serum testosterone levels.
Carson, Schlich, Frank, Romanelli
openaire +2 more sources
Weekly Versus Monthly Testosterone Administration On Fast and Slow Skeletal Muscle Fibers in Older Adult Males [PDF]
, 2014 Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types
Dillon, E. Lichar +5 more
core +2 more sources
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
Asian Journal of Andrology, 2015 The role of testosterone in the cardiovascular (CV) health of men is controversial. Data suggest that both the condition and treatment of clinical hypogonadism is associated with decreased CV mortality; however, two recent studies suggest that ...
Kathleen Hwang, Martin Miner
doaj +1 more source
Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure [PDF]
, 2006 Background - Testosterone deficiency is a common occurrence in men with chronic heart failure (CHF) and may underpin features of advanced disease, including reduced skeletal muscle mass and fatigue.
John M Saxton +20 more
core +2 more sources
Endocrinologic Control of Men's Sexual Desire and Arousal/Erection [PDF]
, 2016 Several hormones and neurotransmitters orchestrate men's sexual response, including the appetitive (sexual desire) and consummative (arousal and penile erection) phases.
Aversa, Antonio +4 more
core +1 more source
Central serous chorioretinopathy secondary to intramuscular testosterone therapy
Endocrinology, Diabetes & Metabolism Case Reports, 2023 A patient treated with intramuscular testosterone replacement therapy for primary hypogonadism developed blurred vision shortly after receiving his testosterone injection.
M Lockhart +6 more
doaj +1 more source
Impact of testosterone levels and testosterone replacement ther-apy on men’s health
Journal of Medical Science, 2023 Various studies have shown that testosterone levels heavily impact many areas of a man’s health. Low serum testosterone (and, by analogy, late onset hypogonadism) may be responsible for such conditions as type 2 diabetes, obesity in abdominal area ...
Zuzanna Karbowska +5 more
doaj +1 more source